Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312110042> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4312110042 abstract "Treatment of hemophilia A in Brazil is offered to all patients at no cost. However, several unmet medical needs exist.In this study, we applied the Delphi method to discuss with seven hemophilia A specialists the challenges that patients and the health system face regarding hemophilia A treatment and opportunities for improvement.A consensus was obtained regarding the number of weekly infusions and patient adherence to treatment. The bleeding profile, unfavourable pharmacokinetics (PKs), low adherence and high daily activity were patient profiles that would benefit from using the extended half-life (EHL) recombinant factor VIII (rFVIII). The advantages of treatment with the EHL rFVIII were the lower number of infusions per week, which could increase patient adherence and decrease the risk of bleeds, due to a more constant plasma level, a lower value. Additionally, the EHL rFVIII could improve quality of life, especially in patients with high daily activity, such as adolescents and young adults. The panelists mentioned that EHL rFVIII, if available, could be offered first to the priority group (adolescents between 12 and 19 years old), followed by adults (20 to 64 years old) and elderly people (over 65 years old).In summary, the EHL rFVIII offers the optimal prophylaxis by decreasing the dose frequency, increasing the treatment adherence and improving the QoL, without compromising safety and efficacy." @default.
- W4312110042 created "2023-01-04" @default.
- W4312110042 creator A5002893624 @default.
- W4312110042 creator A5022531380 @default.
- W4312110042 creator A5026577570 @default.
- W4312110042 creator A5031036531 @default.
- W4312110042 creator A5033744481 @default.
- W4312110042 creator A5044568175 @default.
- W4312110042 creator A5050952903 @default.
- W4312110042 creator A5086624452 @default.
- W4312110042 date "2022-12-01" @default.
- W4312110042 modified "2023-10-18" @default.
- W4312110042 title "Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement" @default.
- W4312110042 cites W1974965024 @default.
- W4312110042 cites W1999372273 @default.
- W4312110042 cites W2007367842 @default.
- W4312110042 cites W2043906969 @default.
- W4312110042 cites W2062520517 @default.
- W4312110042 cites W2067732954 @default.
- W4312110042 cites W2093913365 @default.
- W4312110042 cites W2117023235 @default.
- W4312110042 cites W2153534018 @default.
- W4312110042 cites W2400420884 @default.
- W4312110042 cites W2557462868 @default.
- W4312110042 cites W2566584570 @default.
- W4312110042 cites W2902206805 @default.
- W4312110042 cites W2950843447 @default.
- W4312110042 cites W2973226749 @default.
- W4312110042 cites W2981289366 @default.
- W4312110042 cites W3047046471 @default.
- W4312110042 cites W3118996547 @default.
- W4312110042 doi "https://doi.org/10.1016/j.htct.2022.11.008" @default.
- W4312110042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36604239" @default.
- W4312110042 hasPublicationYear "2022" @default.
- W4312110042 type Work @default.
- W4312110042 citedByCount "0" @default.
- W4312110042 crossrefType "journal-article" @default.
- W4312110042 hasAuthorship W4312110042A5002893624 @default.
- W4312110042 hasAuthorship W4312110042A5022531380 @default.
- W4312110042 hasAuthorship W4312110042A5026577570 @default.
- W4312110042 hasAuthorship W4312110042A5031036531 @default.
- W4312110042 hasAuthorship W4312110042A5033744481 @default.
- W4312110042 hasAuthorship W4312110042A5044568175 @default.
- W4312110042 hasAuthorship W4312110042A5050952903 @default.
- W4312110042 hasAuthorship W4312110042A5086624452 @default.
- W4312110042 hasBestOaLocation W43121100421 @default.
- W4312110042 hasConcept C105795698 @default.
- W4312110042 hasConcept C159110408 @default.
- W4312110042 hasConcept C187212893 @default.
- W4312110042 hasConcept C2779951463 @default.
- W4312110042 hasConcept C33923547 @default.
- W4312110042 hasConcept C60641444 @default.
- W4312110042 hasConcept C71924100 @default.
- W4312110042 hasConceptScore W4312110042C105795698 @default.
- W4312110042 hasConceptScore W4312110042C159110408 @default.
- W4312110042 hasConceptScore W4312110042C187212893 @default.
- W4312110042 hasConceptScore W4312110042C2779951463 @default.
- W4312110042 hasConceptScore W4312110042C33923547 @default.
- W4312110042 hasConceptScore W4312110042C60641444 @default.
- W4312110042 hasConceptScore W4312110042C71924100 @default.
- W4312110042 hasLocation W43121100421 @default.
- W4312110042 hasLocation W43121100422 @default.
- W4312110042 hasOpenAccess W4312110042 @default.
- W4312110042 hasPrimaryLocation W43121100421 @default.
- W4312110042 hasRelatedWork W1995515455 @default.
- W4312110042 hasRelatedWork W2044172210 @default.
- W4312110042 hasRelatedWork W2080531066 @default.
- W4312110042 hasRelatedWork W2138127085 @default.
- W4312110042 hasRelatedWork W2748952813 @default.
- W4312110042 hasRelatedWork W2899084033 @default.
- W4312110042 hasRelatedWork W2976372530 @default.
- W4312110042 hasRelatedWork W3031052312 @default.
- W4312110042 hasRelatedWork W3032375762 @default.
- W4312110042 hasRelatedWork W3108674512 @default.
- W4312110042 isParatext "false" @default.
- W4312110042 isRetracted "false" @default.
- W4312110042 workType "article" @default.